Discover Great Companies Discover Great Clients
Popularity  4.7万   |   Followers  12   |   Likes  48   |   Feedback  3 Claim this company

With the corporate vision of "professional, dedicated and devoted to t

No.146 Qixia District Popularity Ranking Nanjing Jiangsu No.4 Salt Industries No.7 Yi Yao Ji Group No.8 Health Products No.8 Yao Products R&D Outsourcing No.10 Pharmaceutical Contracts R&D No.10 CRO No.10 Pharmaceutical CRO No.10 Generic Drugs No.12 Zhong Pharmaceuticals No.12 Pharmaceutical Intermediates No.13 Agriculture Chemical No.17 Chemicals Engineering 副会长单位 会长单位 ISO9001认证 药品生产许可证
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 18年
  • Industry: Pharmaceutical/Bioengineering 、 Trade/Import and Export 、 Petroleum/Chemicals/Minerals/Geology
  • Full name: Jiangsu Kaiyuan Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #4 in Nanjing Salt Industries Company by popularity Ranked #7 in Nanjing Yi Yao Ji Group Company by popularity Ranked #8 in Nanjing Health Products Company by popularity Ranked #8 in Nanjing Yao Products R&D Outsourcing Company by popularity
  • Honors: 副会长单位 会长单位 According to algorithm
  • Salary: 66.2% of positions earn 8-15K, In 2026 vs last yeardecreased by 5%.。Master's salary: ¥30.6K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 35.1%, "Medical & Health/Beauty & Healthcare": 17.6%, "Other (R&D and Technical)": 13.5%。
  • Recruiting: In 2026 vs 2025decreased by 45%. Demand for highly educated talent: Master's: 1.
  • Requirement: Education: 本科 leads with 63.5%. Experience: 3-5年 leads with 32.4%.
  • Region: Distributed across 2 regions, 南京: 78.4%, 宿州: 21.6%.

About the Company

[Summary] With the corporate vision of "professional, dedicated and devoted to t

Jiangsu Kaiyuan Pharmaceutical Co., Ltd. was founded in 2008 and is headquartered in Jiangsu Life Science Park, Qixia High-tech Zone, Nanjing City, Jiangsu Province. It currently has more than 500 employees and 7 wholly-owned subsidiaries, and is a comprehensive international biopharmaceutical enterprise integrating biopharmaceutical R&D, production and trade. Its main products cover pharmaceutical intermediates, APIs, finished drugs and medical devices. It engages in R&D activities such as generic drug consistency evaluation, improved new drugs and innovative drug R&D, and MAH, and owns several CDMO production bases for pharmaceutical intermediates, APIs and finished drugs. The company takes industry as support, R&D to drive trade, and trade to promote development. Adhering to a customer-centric approach and oriented by enhancing corporate value, it strives to provide customers with high-quality, efficient services and technical support, and has gained broader development space by virtue of high quality, excellent service and a good brand. It enjoys high visibility and a good reputation in the international and domestic biopharmaceutical and healthcare fields. The headquarters, Kaiyuan Pharmaceutical, is committed to the import and export trade of pharmaceutical and healthcare products. Its traded products include pharmaceutical intermediates, APIs, finished drugs, medical devices, etc., and are sold to more than 120 countries or regions such as the United States, Europe, Russia, India, the Middle East, Africa, Asia-Pacific and South America. It has formed long-term stable cooperative relations with more than 5,000 customers. The company's annual export value exceeds US$200 million and annual sales exceed RMB 1.5 billion. It has been awarded the title of "Top Ten Western and Finished Drug Export Enterprises" by the China Chamber of Commerce for Import and Export of Medicines and Health Products for 9 consecutive years, and has been ranked among the "Top 100 Chinese Pharmaceutical Internationalization Enterprises" for 6 consecutive years. In 2017, the company was successfully elected as Vice Chairman Unit of the China Chamber of Commerce for Import and Export of Medicines and Health Products. The core subsidiary Kaiyuan Pharmaceutical Industry is committed to the field of drug R&D, with an R&D center covering an area of 4,000 square meters and a professional core technical team of more than 100 people, specializing in R&D activities such as chemical small-molecule innovative drug development, generic drug consistency evaluation, CRO and MAH. It has established industry-university-research cooperation relations with many institutions and research units such as China Pharmaceutical University and Nanjing University of Chinese Medicine, and has reached pharmaceutical R&D strategic cooperation with well-known domestic pharmaceutical enterprises such as Sinopharm Group, Guangzhou Pharmaceutical Group, Guobang Pharmaceutical Group and Dingtai Pharmaceutical Research Group. Beijia Pharmaceutical is located in "China Medical City" in Taizhou, Jiangsu, and is one of Kaiyuan Pharmaceutical's formulation production bases. Its main business includes export entrusted production, MAH entrusted production, etc. It has GMP-compliant production workshops for tablets and hard capsules, holds production approvals for three drugs of two products, namely Cefadroxil Capsules and Chloramphenicol Capsules, holds the Drug Production License for capsules, tablets, oral solutions and granules, and has completed six drug production lines with an annual capacity of 1 billion capsules/tablets and 30 million bottles of oral solutions. It can simultaneously meet large-batch entrusted drug processing and production for domestic and foreign customers. Kaiyuan Pharmaceutical is located in Suzhou Economic Development Zone, Anhui, covering an area of 300 mu, and is one of Kaiyuan Pharmaceutical's production bases. The total investment is RMB 1 billion. The Phase I construction project implements projects such as "annual production of 600 tons of fosfomycin levoamine salt, 250 tons of fosfomycin calcium, 50 tons of fosfomycin sodium, 50 tons of fosfomycin trometamol and 1,000 kg of sucrose octasulfate salt". After the Phase I project is put into production, the annual output value will be RMB 500 million, and the Phase II project is under preparation. Due to the different work contents and nature of each subsidiary, there are slight differences in various benefits and working hours. For details, please consult the person in charge of each subsidiary.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Kaiyuan Pharmaceutical How Fast Is Hiring Growing? (30 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 119%
  • 2024: Up 30%
  • 2023: Down 3%
  • 2022: Down 55%
Kaiyuan Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Kaiyuan Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Master's 1
Note: How fast is hiring at Jiangsu Kaiyuan Pharmaceutical Co., Ltd. growing? Kaiyuan Pharmaceutical2026: 52 openings (down 45%), 2025: 94 openings (up 119%), 2024: 43 openings (up 30%), 2023: 33 openings (down 3%), 2022: 34 openings (down 55%), 2021: 76 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Kaiyuan Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Jiangsu Kaiyuan Pharmaceutical Co., Ltd.? Based on an analysis of Kaiyuan Pharmaceutical's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 35.1%, "Medical & Health/Beauty & Healthcare": 17.6%, "Other (R&D and Technical)": 13.5%, "Computer/Network/Technology": 12.2%, "Scientific Research": 6.8%, "Mechanical/Instrumentation": 1.4%. For reference only.

Kaiyuan Pharmaceutical — What Are the Salaries Like? (74 records)

Manage
Kaiyuan Pharmaceutical Salary Overview
salary range: 6K - 50K, 66.2% of roles pay ¥8-15K
Note: salary statistics are based on 74 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangsu Kaiyuan Pharmaceutical Co., Ltd.?Kaiyuan Pharmaceutical66.2% of positions earn 8-15K, Undergraduate salary: ¥。Nanjing salary ranking top 45,生物/制药/化工/环保类 average salary ¥15.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Kaiyuan Pharmaceutical

(More)
Are salaries high at Jiangsu Kaiyuan Pharmaceutical Co., Ltd.? We provide: QA, Researcher, seo, 短视频, Director, 外贸业务, 安环总监, Marketing, Assistant Manager, 药品注册, 药物制剂, Business Development, cro, QC, 业务员, Analyst, 制剂总监, Synthesis Supervisor, 商务主管, Business Manager. Click to view detailed salary analysis by job.

Kaiyuan Pharmaceutical honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 生物/制药/化工/环保类
    35.1% of total 35.1%
  • 经营管理类
    32.4% of total 32.4%
  • 医疗卫生/美容保健类
    17.6% of total 17.6%
  • 贸易/物流/采购/运输类
    17.6% of total 17.6%

Education

  • 本科
    63.5% of total 63.5%
  • 大专
    27% of total 27%
  • 硕士
    5.4% of total 5.4%
  • 高中
    2.7% of total 2.7%

Experience

  • 3-5年
    32.4% of total 32.4%
  • 不限
    28.4% of total 28.4%
  • 1-3年
    23% of total 23%
  • 5-10年
    16.2% of total 16.2%
View Detailed Analysis

What does Jiangsu Kaiyuan Pharmaceutical Co., Ltd. require? Who is Kaiyuan Pharmaceutical hiring? Kaiyuan Pharmaceutical recruitment: 生物/制药/化工/环保类占比最多占35.1%,其次是经营管理类占32.4%. What education can get in at Kaiyuan Pharmaceutical? 本科占比最多占63.5%,其次是大专占27%. High education required at Kaiyuan Pharmaceutical? 硕士占5.4%. Work experience required at Kaiyuan Pharmaceutical? 3-5年占比最多占32.4%,其次是不限占28.4%. Where are the job locations at Kaiyuan Pharmaceutical? 南京占比最多占78.4%,其次是宿州占21.6%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 4,545.4667万(元)
Legal Representative: 燕立波
Date Established:
Credit Code: 913200006811494595
Registered Address: 南京市栖霞区纬地路9号5幢

Partners & Suppliers

江苏开元医药与中国药科大学建立联合实验室,进行药物制剂和合成工艺研究。 Source
供应商 高校/研究院合作
江苏开元医药与南京大学开展产学研合作,共同进行新药研发和技术攻关。 Source
供应商 高校/研究院合作
浙江新和成向江苏开元医药供应维生素类原料药及中间体。 Source
供应商 原料药供应
浙江华海药业向江苏开元医药提供原料药及中间体。 Source
供应商 原料药供应
浙江海正药业向江苏开元医药供应原料药,用于制剂生产。 Source
供应商 原料药供应

People who follow Kaiyuan Pharmaceutical also follow

Kaiyuan Pharmaceutical Competitors (Similar Companies)

药物研发 医疗科技 生物医药 医药中间体
“To become a world-class chemical new materials company with global ope”
“Pharmaceutical enterprise”
“Supplier of pharmaceutical and cosmetic raw materials and fragrance ra”
“A high-tech pharmaceutical enterprise engaged in the full-industry-cha”
复合材料 胶粘剂 结构胶 高性能纤维
进出口/国际贸易 跨境电商/外贸 天然香料 食品添加剂
“主营医药中间体、原料药和成品药的研发、生产与销售”
环保/节能 水处理设备 环保设备制造/加工 污水处理
化工/化学 工程设计 分离设备 甲醇
新材料 聚氨酯 多元醇 聚醚多元醇
化工/化学 化学品 精细化学品 皮革化学品
“Core member enterprise of China National Machinery Industry Corporatio”
零售 药品零售 生产 研发
原料药 医药原料 化工/化学中间体 研发

Discover Great Companies, Discover Great Clients

南京公司名录 南京“Qixia District”公司名录 南京“农化/农业化工”公司名录 南京“中间体”公司名录 南京“进出口贸易”公司名录 南京“新药研发”公司名录 南京“药物研发外包”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates